EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases

Xiuyi Ou, Sa Liu, Pengcheng Sun, Yuanying Yang, Yangchun Xie iD, Bikui Zhang, Yuanjian Li, Wenqun Li iD, Taoli Sun

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Xiuyi Ou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Drug Repositioning, Cardiovascular Diseases, Cardiovascular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: National Natural Scientific Foundation of China, Hunan Provincial Natural Scientific Foundation, Hunan Provincial Education Department Funding Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) remains the major burden on global health. However, the development and approval of novel CVD therapeutics have declined, largely due to their protracted timelines and prohibitive costs. Drug repurposing has emerged as a promising strategy to overcome these limitations by leveraging data from approved drugs, thereby reducing both developmental costs and time‐to‐application. In this review, we systematically evaluate the repurposing potential of currently available drugs for CVD, elucidating their potential mechanisms, efficacy, and safety profiles. Furthermore, we discuss methodologies that facilitate the identification of promising repurposing candidates. These approaches may yield safer, more efficacious, and cost‐effective alternatives for CVD, bridging the gap between clinical needs and drug development pipelines. We also address the translational and commercial barriers specific to CVD drug repurposing and propose that integrating precision medicine, artificial intelligence driven discovery, and collaborative frameworks represents a viable strategy to overcome these hurdles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningCardiovascular DiseasesCardiovascular AgentsHumansDrug DiscoveryAnimals

Stichwörter der Autor:innen

cardiovascular diseasesclinical translationdrug discoverydrug repurposingdrug targets

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Medicated Food and Dietotherapy Reasearch Institute, Hunan Academy of Chinese Medicine, Changsha, Hunan, China.
  • Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China.

ORCID-Profile: Yangchun Xie, Wenqun Li

Förderung

  • National Natural Scientific Foundation of China
  • Hunan Provincial Natural Scientific Foundation
  • Hunan Provincial Education Department Funding Research Project
  • Scientific Research Project of Hunan Provincial Health Commission

Zitieren

APA

Ou, X., Liu, S., Sun, P., Yang, Y., Xie, Y., Zhang, B., Li, Y., Li, W., & Sun, T. (2026). Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70272

Vancouver

Ou X, Liu S, Sun P, Yang Y, Xie Y, Zhang B, et al. Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70272

BibTeX
@article{Ou2026,
  author = {Ou, Xiuyi and Liu, Sa and Sun, Pengcheng and Yang, Yuanying and Xie, Yangchun and Zhang, Bikui and Li, Yuanjian and Li, Wenqun and Sun, Taoli},
  title = {Old Drug, New Opportunity: Drug Repurposing in Cardiovascular Diseases},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70272}
}
Kostenlos starten →